arrow
A

Ana Barac

inova schar cancer institute and inova heart and vascular institute
H指数:56
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessment of the HFA-ICOS risk tool for predicting cancer therapy–related cardiac dysfunction: a prospective cohort study

评估HFA-ICOS风险工具在预测癌症治疗相关心脏功能障碍中的价值:一项前瞻性队列研究

2026-08-240
OA
Statins and risk of cardiovascular disease: Emulating a primary prevention trial in breast cancer survivors

他汀类药物与心血管疾病风险:在乳腺癌幸存者中模拟一项一级预防试验

2026-05-290
PRE
Racial differences in breast cancer-specific mortality and CVD-specific mortality after breast cancer in post-menopausal women

绝经后女性乳腺癌患者中,不同种族在乳腺癌特异性死亡率和心血管疾病特异性死亡率方面的差异

2025-12-170
OAAI
Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton’s Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance

靶向肿瘤治疗心血管不良反应的诊断与管理:布鲁顿酪氨酸激酶、免疫检查点及血管内皮生长因子抑制剂的2025年美国心脏病学会精要临床指南

JACC
IF0
2025-12-100
PRE
Social determinants of cardiovascular disease in women with and without breast cancer

女性乳腺癌患者与非乳腺癌患者心血管疾病的社交决定因素

2025-05-210
PRE
The relationship between cardiometabolic abnormalities and mortality in the Women's Health Initiative: A comparison of associations among women with cancer to women without cancer

心血管代谢异常与死亡率之间的关系:女性健康倡议研究——比较有癌症史女性与无癌症史女性的关联性

CANCER
IF5.1
2025-03-120
PRE
Cardiovascular Safety in Oncology Clinical Trials JACC: CardioOncology Primer

肿瘤学临床试验中的心血管安全性 JACC: CardioOncology Primer

2025-02-011
OAAI
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America

心血管肿瘤学与心力衰竭:美国心力衰竭学会的科学声明

2025-02-015
PRE
Quality-of-Care Measures for Cardio-Oncology An IC-OS and ACC Cardio-Oncology Leadership Council Perspective

心血管肿瘤学护理质量评估指标:IC-OS与ACC心血管肿瘤学领导委员会观点

2025-01-010
OAAI